Doris-Ann, Ashleigh and the Chairs of the Regulatory Affairs Working Party met with the senior leadership of MHRA on 1 April. The aim of the meeting was to discuss the ongoing changes affecting the IVD industry, such as the changes to the structure of MHRA and the upcoming UKCA Regulations. MHRA provided reassurance that they are trying to move as…
Ben KempApril 8, 2022

